All, N = 31 | HC group, n = 15 | PD group, n = 16 | P (HC group vs. PD group) | |
---|---|---|---|---|
Age (y) | 63.55 ± 8.31 | 61.47 ± 5.56 | 65.50 ± 10.04 | 0.17 |
Sex (M/F) | 17/14 | 8/7 | 9/7 | 0.87 |
Disease duration (y) | - | - | 6.19 ± 3.85 | - |
MMSE score | 27.61 ± 3.48 | 29.67 ± 0.72 | 25.69 ± 3.94 | 0.00 |
MoCA score | 24.90 ± 4.25 | 28.00 ± 2.03 | 22.00 ± 3.70 | 0.00 |
H & Y stage (II/III) | - | - | 1.85 ± 0.59 | - |
UPDRS score | - | - | 32.75 ± 12.37 | - |
UPDRS-I score | - | - | 2.75 ± 2.04 | - |
UPDRS-II score | - | - | 10.56 ± 5.89 | - |
UPDRS-III score | - | - | 18.00 ± 5.85 | - |
UPDRS-IV score | - | - | 1.44 ± 2.06 | - |
FOGQ score | - | - | 6.75 ± 5.04 | - |
HAMA score | - | - | 10.25 ± 8.59 | - |
HRSD score | - | - | 10.19 ± 6.86 | - |
PSQI score | - | - | 9.19 ± 4.69 | - |